利用影像学对肝病进行人工智能预后预测
本叙述性综述概述了人工智能(AI)在慢性肝病(CLD)预后模型中的应用,涵盖超声、CT和MRI,重点讨论分割、检测和分类任务如何提取影像特征或直接构建预测模型;文章以预后终点为框架梳理AI-based US、CT和MRI预后模型,并评估当前阻碍临床转化的局限性、关键挑战及未来研究方向。
要点
- AI可对CLD患者US、CT、MRI进行分割、检测和分类,有潜力改善肝相关结局的预后模型。
- 综述按预后终点分类梳理AI-based US、CT和MRI预后模型。
- 文章评估了当前阻碍AI预后模型临床转化的局限性并提出未来研究方向。
核心结论
- AI在慢性肝病影像预后模型中有潜力,但当前存在阻碍临床转化的局限性,需应对CLD预后预测的关键挑战并开展未来研究。
研究设计与样本
- 叙述性综述,概述AI在US、CT和MRI预后模型中的优势、劣势与纳入方法,并以预后终点为框架检查AI-based US、CT和MRI预后模型。
局限性
- 文章评估了当前阻碍AI预后模型临床转化的局限性(原文未逐条列出具体局限内容)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Accurate prognostic tools in patients with chronic liver disease (CLD) have the potential to improve clinical outcomes and reduce health care costs. Imaging studies of CLD patients analysed using artificial intelligence (AI) algorithms for segmentation, detection and classification tasks have the potential to inform and improve prognostic models for liver-related outcomes. In this narrative review, we provide an overview of the strengths, weaknesses and approaches to inclusion of AI in prognostic models that use ultrasound (US), computed tomography (CT) and magnetic resonance imaging (MRI). We then use a prognostic endpoint-based approach to examine AI-based US, CT and MRI prognostic models in chronic liver disease (CLD). We highlight how AI has been applied to extract imaging features or build predictive models directly, and assess the limitations that currently hinder clinical translation. We also outline key challenges specific to prognostication in CLD and propose directions for future research.
引用
- Chouhan MD, McLean K, Thomas JA, et al. Artificial intelligence prognostication of liver disease using imaging. Br J Radiol. 2026. PMID: 41915049. doi:10.1093/bjr/tqag070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。